RESUMO
A study on the use of natural antimicrobial compounds to improve the microbiological stability of refrigerated amaranth-based homemade fresh pasta is presented in this work. In particular, the antimicrobial activity of thymol, lemon extract, chitosan and grapefruit seed extract (GFSE) has been tested against mesophilic and psychrotrophic bacteria, total coliforms, Staphylococcus spp., yeasts and moulds. A sensory analysis on both fresh and cooked pasta was also run. Results suggest that chitosan and GFSE strongly increase the microbial acceptability limit of the investigated spoilage microorganisms, being the former the most effective. Thymol efficiently reduces the growth of mesophilic bacteria, psychrotrophic bacteria and Staphylococcus spp., whereas it does not affect, substantially, the growth cycle of total coliforms. Lemon extract is the less effective in preventing microbial growth. In fact, it is able to delay only total mesophilic and psychrotrophic bacterial evolution. From a sensorial point of view no significant differences were recorded between the control samples and all the types of loaded amaranth-based pasta.
Assuntos
Amaranthus/microbiologia , Bactérias/crescimento & desenvolvimento , Qualidade de Produtos para o Consumidor , Contaminação de Alimentos/prevenção & controle , Conservação de Alimentos/métodos , Conservantes de Alimentos/farmacologia , Quitosana/farmacologia , Citrus/química , Citrus paradisi/química , Contagem de Colônia Microbiana , Contaminação de Alimentos/análise , Microbiologia de Alimentos , Humanos , Concentração de Íons de Hidrogênio , Testes de Sensibilidade Microbiana , Paladar , Timol/farmacologia , Fatores de TempoRESUMO
In this work a study on the combined effects of chitosan and modified atmosphere packaging (MAP) to improve the microbiological quality of amaranth-based homemade fresh pasta is presented. In particular, two different chitosan concentrations were combined to three different MAP conditions and tested against the following spoilage microorganisms: mesophilic bacteria, Staphylococcus spp., yeasts, moulds and total coliforms. Their viable cell concentrations were monitored for about 2 months at 4 degrees C. Results suggest that there is a combined effect between MAP and chitosan in delaying the microbial quality loss of pasta during storage. Moreover, it was also found that among the tested MAP conditions, the combination of 30:70 N2:CO2 is the most efficient, promoting an extension of the microbial acceptability limit beyond two months.
Assuntos
Amaranthus/microbiologia , Quitosana/farmacologia , Contaminação de Alimentos/prevenção & controle , Embalagem de Alimentos/métodos , Dióxido de Carbono/análise , Dióxido de Carbono/farmacologia , Contagem de Colônia Microbiana , Qualidade de Produtos para o Consumidor , Relação Dose-Resposta a Droga , Contaminação de Alimentos/análise , Microbiologia de Alimentos , Conservantes de Alimentos/farmacologia , Humanos , Nitrogênio/análise , Nitrogênio/farmacologiaRESUMO
BACKGROUND AND PURPOSE: Previous studies on the association between Parkinson's disease (PD) and body mass index (BMI) have reported conflicting results. We investigated the relationship between PD and BMI by a case-control study. METHODS: PD patients were randomly matched to healthy individuals by sex and age. BMI distribution in cases has been compared with BMI of controls and odd ratios (ORs) with 95% CI were calculated. RESULTS: We included 318 PD patients and 318 controls. We observed no association between PD and BMI. BMI distribution in cases and controls was similar also when we adjusted for diabetes, hypercholesterolemia and the time elapsed between PD onset and the interview (OR = 0.99; CI = 0.94-1.03; P = 0.51). CONCLUSIONS: These results did not confirm the previously reported association between PD and BMI. Population characteristics and methodological issues may partially account for the differences observed between the present study and the others.
Assuntos
Índice de Massa Corporal , Doença de Parkinson/epidemiologia , Adulto , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Café , Comorbidade , Diabetes Mellitus/epidemiologia , Feminino , Humanos , Hipercolesterolemia/epidemiologia , Hipertrigliceridemia/epidemiologia , Masculino , Pessoa de Meia-Idade , Obesidade/epidemiologia , Sobrepeso/epidemiologia , Fatores de Risco , Fumar/epidemiologia , Aumento de Peso , Redução de PesoRESUMO
We propose an easy-to-construct digital video editing system ideal to produce video documentation and still images. A digital video editing system applicable to many video sources in the operating room is described in detail. The proposed system has proved easy to use and permits one to obtain videography quickly and easily. Mixing different streams of video input from all the devices in use in the operating room, the application of filters and effects produces a final, professional end-product. Recording on a DVD provides an inexpensive, portable and easy-to-use medium to store or re-edit or tape at a later time. From stored videography it is easy to extract high-quality, still images useful for teaching, presentations and publications. In conclusion digital videography and still photography can easily be recorded by the proposed system, producing high-quality video recording. The use of firewire ports provides good compatibility with next-generation hardware and software. The high standard of quality makes the proposed system one of the lowest priced products available today.
Assuntos
Periféricos de Computador/normas , Processamento de Imagem Assistida por Computador/instrumentação , Monitorização Intraoperatória/instrumentação , Procedimentos Neurocirúrgicos/instrumentação , Sistemas de Informação em Salas Cirúrgicas , Salas Cirúrgicas , Gravação em Vídeo/instrumentação , Periféricos de Computador/economia , Computadores/economia , Computadores/normas , Análise Custo-Benefício , Sistemas de Gerenciamento de Base de Dados , Eletrônica Médica/economia , Eletrônica Médica/normas , Humanos , Processamento de Imagem Assistida por Computador/economia , Processamento de Imagem Assistida por Computador/métodos , Bibliotecas Digitais/economia , Bibliotecas Digitais/normas , Monitorização Intraoperatória/economia , Monitorização Intraoperatória/métodos , Procedimentos Neurocirúrgicos/métodos , Sistemas de Informação em Salas Cirúrgicas/economia , Sistemas de Informação em Salas Cirúrgicas/normas , Integração de Sistemas , Gravação em Vídeo/economia , Gravação em Vídeo/métodosRESUMO
BACKGROUND: The osteo-dural decompression of the cerebellar tonsils at the cranio-cervical junction is generally considered the most effective treatment for syringomyelia-Chiari I complex. However much controversy concerning a great number of surgical adjuvants to the standard bony decompression is still present. In this work an extra-arachnoidal cranio-cervical decompression (CCD) without duroplasty is described and the surgical results are reported. METHOD: Between 2000 and 2005, 24 adult patients underwent surgery for symptomatic syringomyelia-Chiari I complex not associated with hydrocephalus. In all cases, the surgical procedure consisted of a limited suboccipital craniectomy and laminectomy of C1 (when necessary C2 as well) followed by dural opening leaving the arachnoid membrane intact. The dura mater is left open and stitched laterally to the muscles. FINDINGS: With a mean clinical long term follow-up of 44 months (range, 12-78 mo), neurological disturbances improved in 21 of 24 patients (87.5%) as result of extra-arachnoidal CCD. The postoperative complications occurred when the arachnoid was accidentally violated (4 cases, 16.6%). The complications included aseptic meningitis (one patient), nucal pseudomeningocele (two patients) and postoperative hydrocephalus requiring a ventriculoperitoneal shunt (one patient). Finally, one patient received an additional C2 laminectomy in order to obtain symptoms improvement and syrinx shrinkage. Postoperative MRI studies demonstrated that the syrinx decreased in size or collapsed in 20 patients (83.3%) and stabilized in 4 (16.7%). CONCLUSIONS: The extra-arachnoidal CCD is a safe and effective treatment for syringomyelia associated with Chiari I malformation in adults without intraoperative evidence of adhesive arachnoiditis. However a larger number of patients and longer follow-up will be necessary to determine the efficacy of extra-arachnoidal CCD.
Assuntos
Malformação de Arnold-Chiari/cirurgia , Descompressão Cirúrgica/métodos , Siringomielia/cirurgia , Adulto , Idoso , Aracnoide-Máter/cirurgia , Malformação de Arnold-Chiari/diagnóstico , Craniotomia/métodos , Dura-Máter/cirurgia , Encefalocele/diagnóstico , Encefalocele/cirurgia , Feminino , Seguimentos , Humanos , Laminectomia/métodos , Masculino , Pessoa de Meia-Idade , Exame Neurológico , Complicações Pós-Operatórias/etiologia , Fatores de Risco , Instrumentos Cirúrgicos , Siringomielia/diagnósticoRESUMO
Tumour-to-tumour metastasis is a rare pathological entity. Meningioma is the most common intracranial tumour to host metastases, the majority of which arise from breast and lung cancers. We present the first report of a colonic cancer metastasis within an intracranial meningioma.A 76-year-old woman presented with a one month history of partial seizures. Her medical history included resection of an adenocarcinoma of the descending colon followed by adjuvant chemotherapy 1 year before our evaluation. Magnetic resonance imaging revealed a homogeneously enhancing lesion in the right frontal convexity.A well capsulated tumour attached to the frontal dura was surgically removed. The pathological examination demonstrated a mixture of fibrous meningioma and colloid adenocarcinoma. Possible explanations for the development of a cohesive chimeric mass of composite pathology are investigated.
Assuntos
Adenocarcinoma/secundário , Adenocarcinoma/cirurgia , Neoplasias do Colo/cirurgia , Neoplasias Meníngeas/secundário , Neoplasias Meníngeas/cirurgia , Meningioma/cirurgia , Segunda Neoplasia Primária/cirurgia , Adenocarcinoma/diagnóstico , Adenocarcinoma/patologia , Idoso , Colectomia , Neoplasias do Colo/diagnóstico , Neoplasias do Colo/patologia , Craniotomia , Feminino , Humanos , Imageamento por Ressonância Magnética , Neoplasias Meníngeas/diagnóstico , Neoplasias Meníngeas/patologia , Meningioma/diagnóstico , Meningioma/patologia , Segunda Neoplasia Primária/diagnóstico , Segunda Neoplasia Primária/patologia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/patologia , Complicações Pós-Operatórias/cirurgia , ReoperaçãoRESUMO
OBJECTIVE: Mortality caused by invasive fungal infections due to filamentous fungi (IFI-FF) is high. Predisposing factors to IFI-FF are multiple and should be stratified. The objective of this study was to identify key risk factors for IFI-FF in onco-haematological patients in different clinical settings. METHODS: Prospective national Delphi study. Risk factors for IFI-FF in patients with onco-haematological diseases were identified by a systematic review of the literature. An anonymous survey was sent by e-mail to a panel of experts. A key risk factor was defined when at least 70% of the surveyed participants assigned a "maximal" or "high" risk. RESULTS: In allogenic stem cell transplantation, 18 of the 42 risk factors analyzed were classified as key risk factors, including neutropenia, previous IFI-FF, grade III/IV acute or extensive chronic graft-versus-host disease (GVHD), umbilical cord blood transplantation, HLA mismatching transplantation, graft failure, absence of HEPA filters, absence of laminar air flow, diagnosis of acute myeloid leukaemia, haploidentical transplantation, anti-TNF-α drugs, alemtuzumab, anti-thymocyte globulin, immunosuppressive prophylaxis for GVHD, lymphocytopenia, cytomegalovirus infection, and proximity to construction areas. In acute leukaemia/myelodysplastic syndrome (AL/MDS), 7 of 25 risk factors were defined as key risk factors, including neutropenia, consolidation therapy without response, induction therapy, antifungal prophylaxis with azoles, proximity to construction areas, and absence of HEPA filters. In lymphoma/multiple myeloma (MM), the five key risk factors among 21 analyzed were use of steroids, neutropenia, progressive disease, anti-CD52 therapies, and proximity to construction areas. CONCLUSIONS: The Delphi method was useful for the classification and stratification of risk factors for IFI-FF in patients with onco-haematological diseases. Identifying key risk factors will contribute to a better management of IFI-FF in this group of patients at high or changing risk.
Assuntos
Doenças Hematológicas/complicações , Doenças Hematológicas/epidemiologia , Infecções Fúngicas Invasivas/epidemiologia , Transplante de Células-Tronco de Sangue do Cordão Umbilical , Técnica Delphi , Fungos , Rejeição de Enxerto/complicações , Doença Enxerto-Hospedeiro/complicações , Doença Enxerto-Hospedeiro/epidemiologia , Doenças Hematológicas/mortalidade , Neoplasias Hematológicas/complicações , Transplante de Células-Tronco Hematopoéticas , Humanos , Infecções Fúngicas Invasivas/mortalidade , Infecções Fúngicas Invasivas/terapia , Neutropenia/epidemiologia , Estudos Prospectivos , Medição de Risco , Fatores de RiscoRESUMO
In the central nervous system (CNS), cytokine-primed microglia play a central role in host's defense against Acanthamoeba castellanii infection. In this study, the effect of recombinant interferon (rIFN)-gamma and Salmonella enterica serovar enteritidis lipopolysaccharide (LPS), both inflammatory stimuli, on A. castellanii infection in murine microglia was examined. Priming of microglia with rIFN-gamma and LPS synergistically triggered, in a dose-dependent manner, amebastatic activity in these cells. More than 52%, 88% or 95% of this function was then abrogated by anti-IL-1beta (but not anti-IL-1alpha), IL-6 or TNF-alpha neutralizing antibodies, suggesting that these endogenously produced cytokines may participate in the antimicrobial capacity. Consistent with these findings, the priming of microglia with rIFN-gamma and LPS elicited the release of proinflammatory interleukin (IL)-1alpha, IL-1beta, IL-6 and tumor necrosis factor (TNF)-alpha. Since L-canavanine affected amebastatic activity only during the priming process but not during the infection process, NO-dependent pathway appears to be not the sole antiparasitic mechanism involved in this function. These data suggest that rIFN-gamma and LPS, likely through a proinflammatory network, up-regulate the release of IL-beta, IL-6 and TNF-alpha, which could trigger antimicrobial activity against A. castellanii infection in the brain.
Assuntos
Acanthamoeba/efeitos dos fármacos , Amebíase/tratamento farmacológico , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Microglia/efeitos dos fármacos , Amebíase/imunologia , Amebíase/microbiologia , Animais , Anticorpos Bloqueadores/farmacologia , Canavanina/farmacologia , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Citocinas/antagonistas & inibidores , Citocinas/metabolismo , Indicadores e Reagentes , Camundongos , Camundongos Endogâmicos BALB C , Proteínas RecombinantesRESUMO
Heat shock proteins (Hsps) are abundant molecular chaperones participating in the cytoprotection. The kinetics of synthesis of Hsps closely correlates with the kinetics of development of resistance to cell death. In this study, we analysed the probable involvement of Hsp 27 and Hsp 60 in the protection of cells undergoing apoptosis. Human lymphocytes cultured in the presence of ampicillin or ceftriaxone produced Hsp 60 and Hsp 27, estimated by immunoblotting in a time-dependent manner and the increased levels of Hsp 60 and Hsp 27 correlated with enhanced resistance of the lymphocytes to apoptosis, as determined by flow cytometry. Cultures treated with ampicillin or ceftriaxone also exhibited smaller numbers of apoptotic cells than untreated cultures when exposed to the apoptosis-inducing agent staurosporine (1 mM). In contrast, cloramphenicol induced the production of only small amounts of Hsp 60, and no resistance apoptosis. Further studies are needed to clarify the potential role of Hsp 27 and Hsp 60 in the resistance of human cells to apoptosis and the effects of antibiotics on this phenomenon.
Assuntos
Adjuvantes Imunológicos/farmacologia , Antibacterianos/farmacologia , Apoptose/efeitos dos fármacos , Chaperonina 60/biossíntese , Proteínas de Choque Térmico/biossíntese , Linfócitos/metabolismo , Ampicilina/farmacologia , Ceftriaxona/farmacologia , Cloranfenicol/farmacologia , Citometria de Fluxo , Humanos , Immunoblotting , Técnicas In Vitro , Linfócitos/citologia , Fatores de TempoRESUMO
In the central nervous system, cytokine-activated microglia play a crucial role in host defence against Toxoplasma gondii infections. In this study, the effect of recombinant tumor necrosis factor (rTNF)-alpha and prolactin (PRL) on T. gondii infection in microglia was examined. Pretreatment of microglia with rTNF-alpha and PRL induced toxoplasmastatic activity, the intracellular killing of T. gondii and the release of interleukin (IL)-1 beta IL-3 and IL-6: 50% of the intracellular killing was abrogated by anti-ICAM-1 monoclonal antibodies, whereas more than 54 or 87% of toxoplasmastatic activity was reversed by anti-IL-3 or IL-6 monoclonal antibodies. In addition, the treatment of microglia with either rIL-3 or rIL-6, in the absence or presence of rTNF-alpha significantly limited T. gondii replication. Inasmuch as either NMA or S-M-ITU affected cytokine-activated toxoplasmastatic activity during the infection phase, the NO-dependent pathway itself appears not to be directly involved in the parasitostatic activity. These findings suggest that TNF-alpha and PRL up-regulate the expression of ICAM-1 and the production of endogenous IL-6 and IL-3 by microglia, which could induce anti-parasitic functions against T. gondii infection in the brain.
Assuntos
Microglia/parasitologia , Prolactina/fisiologia , Toxoplasma/crescimento & desenvolvimento , Toxoplasmose Cerebral/parasitologia , Fator de Necrose Tumoral alfa/farmacologia , Animais , Anticorpos Monoclonais/imunologia , Interleucina-3/biossíntese , Interleucina-3/imunologia , Interleucina-3/fisiologia , Interleucina-6/biossíntese , Interleucina-6/imunologia , Interleucina-6/fisiologia , Camundongos , Microglia/metabolismo , Proteínas Recombinantes/farmacologia , Toxoplasmose Cerebral/imunologiaRESUMO
Mice and nude rats lethally infected with T. gondii and treated with recombinant rat interferon-gamma (rIFN-gamma) or recombinant human interleukin-2 (rIL-2) were protected against death, when compared with untreated infected controls. In mice rIFN-gamma and rIL-2 played an important role in "prophylactic treatment", but not in "curative therapy". The survival rate was 42% in mice treated with 3 doses of 20,000 U of rIFN-gamma at days -2, -1, 0 before challenge and up to 66% in mice treated with 3 doses of 10,000 U of rIFN-gamma at days -2, 0, +2 before and after infection. Whereas the survival rate was 33% in mice that received 3 doses of 500 U rIL-2 at days -2, -1, 0 before infection, or -2, 0, +2 before and after infection respectively, up to 50% of the mice treated with 3 doses of 1,000 U rIL-2 at days -2, -1, 0 survived. In nude rats rIFN-gamma had a slight effect in "prophylactic treatment", whereas rIL-2 was active only in "curative treatment". The survival rate was 25% both in nude rats treated with doses of 400,000 U of rIFN-gamma at days -3, 0 before challenge, or with doses of 5,000 U of rIL-2 at days +2, +6, +9 after infection. These results lead us to hypothesise that the mechanism by which the lymphokine treatment exerts a protective effect on Toxoplasma infected mice is different from that on nu/nu rats. We conclude that these cytokines may play a notable role in modulating the host's immune defence against T. gondii infection.
Assuntos
Fatores Imunológicos/uso terapêutico , Interferon gama/uso terapêutico , Interleucina-2/uso terapêutico , Toxoplasmose Animal/terapia , Animais , Hospedeiro Imunocomprometido , Fatores Imunológicos/farmacologia , Interferon gama/farmacologia , Interleucina-2/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Ativação de Macrófagos/efeitos dos fármacos , Masculino , Camundongos , Ratos , Ratos Endogâmicos F344 , Ratos Nus/imunologia , Proteínas Recombinantes , Toxoplasmose Animal/imunologia , Toxoplasmose Animal/prevenção & controleRESUMO
We studied effects of monoclonal antibodies on lymphocyte subpopulations in patients with allergic rhinitis treated with histamine2 antagonists. The OKT4/OKT8 ratio after treatment showed a statistically significant decrease compared with initial values, the expression of a relative increase in the OKT8 subpopulation containing the suppressor fraction. In control patients no significant variations were observed. These results confirm our hypothesis that histamine2 antagonists act in allergic rhinitis by modulating the activity of T-suppressor lymphocytes reduced in atopic patients.
Assuntos
Antagonistas dos Receptores H2 da Histamina/farmacologia , Rinite/imunologia , Linfócitos T Reguladores/efeitos dos fármacos , Adolescente , Adulto , Anticorpos Monoclonais , Criança , Feminino , Humanos , Imunoglobulina E/análise , Masculino , Rinite/tratamento farmacológicoRESUMO
Extraction of liver tissue with organic solvent produces coextractants with compounds of interest. The solid-phase extraction (SPE) cleanup of liver tissue developed for ivermectin removes nonpolar coextractants. Liver extract that has been reduced to dryness is reconstituted in 0.5 mL acetonitrile. The mixture is passed through 0.1 g C18 SPE column, and the eluate is collected. The column is eluted further with 2 mL acetonitrile. Combined eluates are derivatized with 1-methylimidazole and trifluoroacetic anhydride, and the ivermectin derivative is determined by liquid chromatography with fluorescence detection.
Assuntos
Anti-Helmínticos/análise , Ivermectina/análise , Fígado/química , Animais , Indicadores e Reagentes , Ivermectina/análogos & derivados , Padrões de ReferênciaRESUMO
Rats are resistant to Toxoplasma infection, and in contrast to mice do not form cysts in their tissues. Because rats treated with beta adrenergics, corticosteroids or 60cobalt are more susceptible to toxoplasmosis, we conducted experiments to investigate if the impaired resistance of drug-treated rats is related to macrophage function or induction of cystogenic capacity. Our experiments in 0.7 or 1.2 mg/kg-corticosteroid or 12 Gy-60cobalt-treated rats indicated that the decreased survival rate (P < 0.001 to P < 0.0001, compared to infected-untreated or infected-unirradiated animals) was associated with a decrease of both macrophage toxoplasmastatic activity and intracellular killing (P < 0.05 each group), compared to infected-untreated or infected-unirradiated rats. However in 9 Gy-60cobalt-treated animals the decreased survival rate (P < 0.001, compared with control rats) was accompanied only by a decrease of the toxoplasmastatic activity in comparison to macrophages of the control animals. Moreover in these animals, the release of NO2- by these macrophages was poorly detectable (P < 0.05) or completely inhibited (P < 0.01) in comparison with infected-untreated or infected-unirradiated rats. In contrast, in all groups of rats treated with high doses of beta adrenergic, the decreased survival (P < 0.001 to P < 0.0001, compared with untreated rats) was accompanied by values of intracellular killing and intracellular proliferation of Toxoplasma parasites that did not significantly (P = ns each group) differ from macrophages of infected-untreated rats. Furthermore in the high beta adrenergic treated groups only small amounts of NO2- were detectable (P < 0.05) in comparison with control animals. In addition, our data in rats treated with 0.7 or 1.2 mg/kg of corticosteroid or 12 Gy of 60cobalt indicated that the increased mortality was correlated to the presence of a small number of cysts in their brains (P < 0.05; P = ns; P < 0.01 respectively) in comparison to infected-untreated or infected-unirradiated rats. These results suggest that the susceptibility of drug-immunosuppressed rats is not due exclusively to a deficient macrophage function, but is probably also linked to immune mechanisms involved in the process of cystogenesis.
Assuntos
Encefalopatias/etiologia , Cistos/etiologia , Macrófagos Peritoneais/imunologia , Toxoplasmose Animal/imunologia , Antagonistas Adrenérgicos beta/farmacologia , Animais , Betametasona/farmacologia , Suscetibilidade a Doenças , Glucocorticoides/farmacologia , Terapia de Imunossupressão , Masculino , Propranolol/farmacologia , Ratos , Ratos Endogâmicos F344 , Toxoplasmose Animal/mortalidade , Toxoplasmose Animal/patologia , Irradiação Corporal TotalRESUMO
Cytokine-activated human vein endothelial cells (HUVEC) may play an important role in resistance to Toxoplasma gondii infection. In this study, it was investigated the role of rTNF-alpha and GH in the induction of antitoxoplasmal activities in HUVEC. Co-treatment of HUVEC with rTNF-alpha plus GH induced both toxoplasmastatic activity and the intracellular killing of T. gondii (p <0.01 each vs untreated cells). Thus, these functions were inhibited by both neutralizing antibodies to IL-6 and GM-CSF (but not to IL-3) suggesting that these cytokines participate in the inhibitory process. Consistent with this hypothesis, the treatment of HUVEC with rIL-6 or rGM-CSF in the presence of rTNF-alpha, limited T. gondii multiplication in a dose-dependent manner (p <0.01 each vs untreated cells). In order to elucidate the inhibitory mechanism of HUVEC, it was assessed by L-arginine analogs (e.g., NG-monomethyl-arginine) whether NO2 molecules originating from HUVEC were directly or indirectly involved in the rTNF-alpha/GH-dependent induction of toxoplasmastatic activity. A good correlation was found between toxoplasmastatic activity and NO2 release during the activation phase, before infection of the HUVEC with T. gondii, but no correlation was found between the parasitostatic activity and NO2 release during the infection phase. These data indicate that NO2- itself does not directly affect toxoplasmastatic activity. Besides, the reduction of intracellular killing by monoclonal antibodies to ICAM-1 suggest that this adhesin plays a role in controlling T. gondii entry into cells.
Assuntos
Citocinas/farmacologia , Endotélio Vascular/parasitologia , Hormônio do Crescimento/farmacologia , Toxoplasma/efeitos dos fármacos , Animais , Moléculas de Adesão Celular/metabolismo , Relação Dose-Resposta a Droga , Interações Medicamentosas , Endotélio Vascular/citologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Humanos , Interleucinas/farmacologia , Testes de Neutralização , Óxido Nítrico/biossíntese , Toxoplasmose/imunologia , Fator de Necrose Tumoral alfa/farmacologia , ômega-N-Metilarginina/farmacologiaRESUMO
Prominent or isolated weakness of cervical extensor muscles is a relatively rare clinical sign. Commonly, this is known as "dropped-head syndrome". This abnormal flexion of the head may occur in a variety of neuromuscular diseases and in a few non-neurological disorders as well. The case we describe concerns a 61-year-old woman with dropped-head syndrome as the unique complaint of myasthenia gravis.
Assuntos
Debilidade Muscular/fisiopatologia , Miastenia Gravis/fisiopatologia , Músculos do Pescoço/fisiopatologia , Vértebras Cervicais/patologia , Vértebras Cervicais/fisiopatologia , Inibidores da Colinesterase/uso terapêutico , Feminino , Cabeça/fisiopatologia , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Debilidade Muscular/tratamento farmacológico , Debilidade Muscular/etiologia , Miastenia Gravis/diagnóstico , Miastenia Gravis/tratamento farmacológico , Músculos do Pescoço/efeitos dos fármacos , Brometo de Piridostigmina/uso terapêutico , Recuperação de Função Fisiológica/efeitos dos fármacos , Recuperação de Função Fisiológica/fisiologia , Resultado do TratamentoRESUMO
We report on an extremely rare case of a paravertebral thoracic mesothelial cyst in a young woman who presented with dorsal radiculopathy affecting the T5 dermatome. The patient underwent a standard transthoracic intercostal approach with removal of the cyst. During the operation, the T5 intercostal neurovascular bundle was found firmly attached to the lesion elucidating the origin of the radicular pain. To our knowledge, this is the first report of radiculopathy due to a paravertebral mesothelial cyst. Although highly unusual, paravertebral mesothelial cyst should be considered in the differential diagnosis for lesions inducing dorsal radicular pain.
Assuntos
Epitélio/patologia , Cisto Mediastínico/complicações , Cisto Mediastínico/patologia , Radiculopatia/etiologia , Radiculopatia/patologia , Cavidade Torácica/patologia , Adulto , Feminino , Humanos , Imageamento por Ressonância Magnética , Cisto Mediastínico/cirurgia , Mediastino/patologia , Mediastino/cirurgia , Radiculopatia/fisiopatologia , Doenças Raras , Nervos Espinhais/patologia , Nervos Espinhais/fisiopatologia , Nervos Espinhais/cirurgia , Cavidade Torácica/fisiopatologia , Cavidade Torácica/cirurgia , Cirurgia Torácica , Vértebras Torácicas/anatomia & histologia , Resultado do TratamentoRESUMO
The data shows that Fisher rats treated with propranolol, betamethasone or exposed to cobalt60-treatment before challenge with T. gondii exhibit an impaired resistance to this opportunistic parasite infection. In fact, in rats propranolol-treatment induces an increase mortality rate up to 66.6% (P < 0.01, with respect to controls). Whereas betamethasone or cobalt60-treatment induces an increased of mortality rate about 33.3% (P < 0.05 respectively, with respect to unirradiated rats). In contrast to beta blocker, corticosteroid-treated or irradiated rats, beta adrenergic-treated rats do not significantly differ from untreated rats in their time of survival. These data lead the authors to hypothesise that in rats the natural resistance to T. gondii can be modulate beta adrenergics or corticosteroids.
Assuntos
Betametasona/farmacologia , Epinefrina/farmacologia , Propranolol/farmacologia , Toxoplasmose Animal/imunologia , Animais , Antígenos de Superfície/análise , Imunidade Inata/efeitos dos fármacos , Imunidade Inata/efeitos da radiação , Ratos , Ratos Endogâmicos F344 , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia , Toxoplasmose Animal/mortalidade , Irradiação Corporal TotalRESUMO
The authors studied the production and effect of interleukin 2 obtained from T lymphocytes stimulated with Aspergillus niger on populations of LGL cells from the peripheral blood and spleen of infected and non-infected mice. The results show an increase in IL-2 production by T lymphocytes in the spleen. In addition, the data demonstrate an increase in LGL activity in the blood and spleen of infected mice. This was seen as the percentage of growth inhibition towards Aspergillus niger, around the tenth day of infection, and reached a maximum of activity on the fifteenth day. The NK activity of the LGL studied increases both in infected and non-infected mice when IL-2 from T lymphocytes of infected mouse blood and spleen is present.